These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32891502)

  • 1. Surface Electrocardiogram Analysis to Improve Risk Stratification for Ventricular Fibrillation in Brugada Syndrome.
    Delinière A; Chevalier P
    Heart Lung Circ; 2021 Feb; 30(2):e47. PubMed ID: 32891502
    [No Abstract]   [Full Text] [Related]  

  • 2. The Brugada syndrome: can we predict the risk?
    Ott P; Marcus F
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):608-9. PubMed ID: 16836707
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of individuals with the Brugada electrocardiogram: a myth or a reality?
    Al-Khatib SM
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):584-5. PubMed ID: 16836702
    [No Abstract]   [Full Text] [Related]  

  • 5. Brugada Syndrome Presenting as Polymorphic Ventricular Tachycardia-Ventricular Fibrillation Lasting 94 Seconds Recorded on an Ambulatory Monitor.
    Russo CR; Welch TD; Sangha RS; Greenberg ML
    JAMA Intern Med; 2015 Dec; 175(12):1951-4. PubMed ID: 26501938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian variations in ST-segment elevation surrounding the spontaneous onset of ventricular fibrillation in Brugada syndrome.
    Kaneko Y; Nakajima T; Ota M; Kurabayashi M
    J Cardiovasc Electrophysiol; 2012 Jun; 23(6):664-5. PubMed ID: 22004590
    [No Abstract]   [Full Text] [Related]  

  • 7. Right Ventricular Outflow Tract Electroanatomical Abnormalities Predict Ventricular Fibrillation Inducibility in Brugada Syndrome.
    Letsas KP; Efremidis M; Asvestas D; Vlachos K; Georgopoulos S; Tse G; Liu T; Bazoukis G; Sideris A; Baranchuk A; Ehrlich JR; Brugada P
    Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005928. PubMed ID: 29437762
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporating Latent Variables Using Nonnegative Matrix Factorization Improves Risk Stratification in Brugada Syndrome.
    Tse G; Zhou J; Lee S; Liu T; Bazoukis G; Mililis P; Wong ICK; Chen C; Xia Y; Kamakura T; Aiba T; Kusano K; Zhang Q; Letsas KP
    J Am Heart Assoc; 2020 Nov; 9(22):e012714. PubMed ID: 33170070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation storm in a child.
    Einbinder T; Lowenthal A; Fogelman R
    Europace; 2014 Nov; 16(11):1654. PubMed ID: 25344961
    [No Abstract]   [Full Text] [Related]  

  • 10. Proarrhythmic ECG deterioration caused by myocardial ischemia of the conus branch artery in patients with a Brugada ECG pattern.
    Ogano M; Iwasaki YK; Morita N; Tanabe J; Shiiba K; Miyauchi Y; Kobayashi Y; Tanaka K; Katoh T; Mizuno K
    Pacing Clin Electrophysiol; 2011 Mar; 34(3):e26-9. PubMed ID: 20353416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation induced by a narrow QRS complex tachycardia in a patient with Brugada syndrome.
    Nagai T; Shimizu W; Ogimoto A; Higaki J; Okayama H
    J Cardiovasc Electrophysiol; 2009 Jan; 20(1):106-7. PubMed ID: 18631271
    [No Abstract]   [Full Text] [Related]  

  • 12. The Utility of Exercise Testing in Risk Stratification of Asymptomatic Patients With Type 1 Brugada Pattern.
    Subramanian M; Prabhu MA; Harikrishnan MS; Shekhar SS; Pai PG; Natarajan K
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):677-683. PubMed ID: 28316113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome.
    Kataoka N; Mizumaki K; Nakatani Y; Sakamoto T; Yamaguchi Y; Tsujino Y; Nishida K; Inoue H
    Heart Rhythm; 2016 Jul; 13(7):1497-503. PubMed ID: 27018377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome.
    Morita H; Miyamoto M; Watanabe A; Tsukuda S; Morimoto Y; Kawada S; Nakagawa K; Nishii N; Ito H
    Heart Rhythm; 2018 Oct; 15(10):1468-1474. PubMed ID: 29953954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods.
    Kawazoe H; Nakano Y; Ochi H; Takagi M; Hayashi Y; Uchimura Y; Tokuyama T; Watanabe Y; Matsumura H; Tomomori S; Sairaku A; Suenari K; Awazu A; Miwa Y; Soejima K; Chayama K; Kihara Y
    Heart Rhythm; 2016 Oct; 13(10):1947-54. PubMed ID: 27424075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
    De Maria E; Cappelli S; Cappato R
    Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing.
    Adler A; Rosso R; Chorin E; Havakuk O; Antzelevitch C; Viskin S
    Heart Rhythm; 2016 Jan; 13(1):299-310. PubMed ID: 26341603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.